Cormorant Asset Management, LP
SEC CIK 1583977 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | Former 10% Owner | 950.0K | $4.00M | $9.79M | 2 | 2024-11-04 | 2026-04-28 |
| EYPT | EyePoint, Inc. | Former 10% Owner | 8.27M | $37.13M | $942.0K | 4 | 2023-12-08 | 2025-12-04 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 10% | 1.48M | $14.25M | — | 1 | 2024-02-02 | 2024-02-02 |
| ERAS | Erasca, Inc. | Dir | 10.81M | $19.20M | — | 4 | 2021-07-20 | 2022-12-13 |
| PYXS | Pyxis Oncology, Inc. | Former 10% Owner | 1.12M | $7.20M | — | 2 | 2021-10-13 | 2021-10-13 |
| IMRX | Immuneering Corp | Former 10% Owner | 1.70M | $8.25M | — | 2 | 2021-08-03 | 2021-08-03 |
Most active insiders at DRUG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cormorant Asset Management, LP | Former 10% Owner | — | $9.79M |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-04-30 16:07 | 2026-04-28 | DRUG | BRIGHT MINDS BIOSCIENCES INC. | Cormorant Asset Management, LP | Former 10% Owner | S - Sale | $89.50 | -109.3K | 950.0K | -10% | -$9.79M |
| I | 2025-12-08 | 2025-12-04 | EYPT | EyePoint, Inc. | Cormorant Asset Management, LP | Former 10% Owner | S - Sale | $15.70 | -60.0K | 8.27M | -0.7% | -$942.0K |
| I | 2024-11-06 | 2024-11-04 | DRUG | BRIGHT MINDS BIOSCIENCES INC. | Cormorant Asset Management, LP | 10% | P - Purchase | $21.70 | +184.3K | 1.06M | +21% | +$4.00M |
| MI | 2024-05-08 | 2024-05-06 | EYPT | EyePoint, Inc. | Cormorant Asset Management, LP | 10% | P - Purchase | $11.86 | +850.0K | 8.12M | +12% | +$10.08M |
| I | 2024-02-06 | 2024-02-02 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Cormorant Asset Management, LP | 10% | P - Purchase | $19.00 | +750.0K | 1.48M | +103% | +$14.25M |
| MI | 2024-01-11 | 2024-01-09+ | EYPT | EyePoint, Inc. | Cormorant Asset Management, LP | 10% | P - Purchase | $19.94 | +855.0K | 6.89M | +14% | +$17.05M |
| I | 2023-12-12 | 2023-12-08 | EYPT | EyePoint, Inc. | Cormorant Asset Management, LP | 10% | P - Purchase | $17.00 | +588.2K | 6.04M | +11% | +$10.00M |
| AI | 2022-12-21 | 2022-12-13 | ERAS | Erasca, Inc. | Cormorant Asset Management, LP | Dir | P - Purchase | $6.50 | +307.7K | 10.81M | +3% | +$2.00M |
| I | 2022-12-20 | 2022-12-13 | ERAS | Erasca, Inc. | Cormorant Asset Management, LP | Dir | P - Purchase | $6.50 | +307.7K | 10.81M | +3% | +$2.00M |
| DI | 2021-10-15 | 2021-10-13 | PYXS | Pyxis Oncology, Inc. | Cormorant Asset Management, LP | Former 10% Owner | P - Purchase | $16.00 | +450.0K | 1.12M | +67% | +$7.20M |
| DI | 2021-10-15 | 2021-10-13 | PYXS | Pyxis Oncology, Inc. | Cormorant Asset Management, LP | Former 10% Owner | C - Cnv Deriv | — | +668.9K | 668.9K | New | — |
| DI | 2021-08-05 | 2021-08-03 | IMRX | Immuneering Corp | Cormorant Asset Management, LP | Former 10% Owner | C - Cnv Deriv | — | +1.70M | 1.70M | New | — |
| DI | 2021-08-05 | 2021-08-03 | IMRX | Immuneering Corp | Cormorant Asset Management, LP | Former 10% Owner | P - Purchase | $15.00 | +550.0K | 2.25M | +32% | +$8.25M |
| DI | 2021-07-22 | 2021-07-20 | ERAS | Erasca, Inc. | Cormorant Asset Management, LP | 10% | C - Cnv Deriv | — | +9.56M | 9.56M | New | — |
| DI | 2021-07-22 | 2021-07-20 | ERAS | Erasca, Inc. | Cormorant Asset Management, LP | 10% | P - Purchase | $16.00 | +950.0K | 10.51M | +10% | +$15.20M |
Purchase Sale Sale after option exercise All abbreviations